Stock A310840 NH SPECIAL PURPOSE ACQUISITION 13 CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News NH Special Purpose Acquisition 13 Co., Ltd.

Equities

A310840

KR7310840004

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CK&B Co.Ltd cancelled the acquisition of NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction.
CI
CK&B Co.Ltd agree to acquire NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction
CI
Angiolab, Inc. cancelled the acquisition of NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction.
CI
Angiolab, Inc. signed a contract to acquire NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction for KRW 66.3 billion.
CI
NH Special Purpose Acquisition 13 Co., Ltd. has completed an IPO in the amount of KRW 6 billion.
CI
NH Special Purpose Acquisition 13 Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A310840 Stock
  4. News NH Special Purpose Acquisition 13 Co., Ltd.